H3C14 |
Q71DI3
|
H3 clustered histone 14
|
|
|
0.861 |
0.154 |
SLEB4 |
|
systemic lupus erythematosus, susceptibility to, 4
|
|
|
0.861 |
0.154 |
RFH1 |
|
Renal failure, progressive, with hypertension
|
|
|
0.861 |
0.154 |
H3C13 |
Q71DI3
|
H3 clustered histone 13
|
|
7.0E-04 |
0.861 |
0.154 |
CHST12 |
Q9NRB3
|
carbohydrate sulfotransferase 12
|
Enzyme
|
4.7E-05 |
0.839 |
0.192 |
H3C15 |
Q71DI3
|
H3 clustered histone 15
|
|
|
0.821 |
0.231 |
TRIM38 |
O00635
|
tripartite motif containing 38
|
|
1.4E-08 |
0.792 |
0.346 |
LBX1-AS1 |
|
LBX1 antisense RNA 1
|
|
|
0.792 |
0.231 |
IFNR |
|
interferon production regulator
|
|
|
0.792 |
0.192 |
NAA16 |
Q6N069
|
N-alpha-acetyltransferase 16, NatA auxiliary subunit
|
Enzyme
|
1.8E-18 |
0.780 |
0.231 |
SNRPA |
P09012
|
small nuclear ribonucleoprotein polypeptide A
|
Nucleic acid binding
|
2.8E-05 |
0.769 |
0.308 |
MIR633 |
|
microRNA 633
|
|
|
0.769 |
0.346 |
PDE8A |
O60658
|
phosphodiesterase 8A
|
|
1.2E-04 |
0.760 |
0.500 |
ABHD6 |
Q9BV23
|
abhydrolase domain containing 6
|
Enzyme
|
2.2E-05 |
0.751 |
0.385 |
SLAMF6 |
Q96DU3
|
SLAM family member 6
|
Enzyme
|
1.9E-02 |
0.751 |
0.346 |
C1QC |
P02747
|
complement C1q C chain
|
|
4.9E-02 |
0.751 |
0.423 |
IFNK |
Q9P0W0
|
interferon kappa
|
|
9.1E-10 |
0.751 |
0.385 |
PHRF1 |
Q9P1Y6
|
PHD and ring finger domains 1
|
|
5.7E-02 |
0.743 |
0.346 |
ELOF1 |
P60002
|
elongation factor 1 homolog
|
|
9.0E-02 |
0.736 |
0.346 |
SIGLEC14 |
Q08ET2
|
sialic acid binding Ig like lectin 14
|
|
1.3E-03 |
0.736 |
0.269 |
MAEA |
Q7L5Y9
|
macrophage erythroblast attacher
|
|
0.23 |
0.736 |
0.385 |
HLA-H |
P01893
|
major histocompatibility complex, class I, H (pseudogene)
|
|
|
0.736 |
0.500 |
OASL |
Q15646
|
2'-5'-oligoadenylate synthetase like
|
Enzyme
|
2.8E-11 |
0.729 |
0.385 |
HIVEP3 |
Q5T1R4
|
HIVEP zinc finger 3
|
|
0.91 |
0.722 |
0.462 |
LILRA3 |
Q8N6C8
|
leukocyte immunoglobulin like receptor A3
|
Receptor
|
1.5E-06 |
0.722 |
0.500 |